Results for aspergillosis translation from French to English

aspergillus and aspergillosis.
bossche hv, mackenzie dwr, cauwenbergh g, eds.

aspergillosis due to carpet contamination.
gerson sl, parker p, jacobs mr et al.

pulmonary aspergillosis during hospital renovation.
arnow pm, andersen rl, mainous pd et al.

j02ax04 secondline treatment of invasive aspergillosis
j02ax04 secondline treatment of invasive aspergillosis

allergic bronchopulmonary aspergillosis from a contaminated dump site.
american review of respiratory disease 140: 1086–1088.

berg r. nosocomial aspergillosis during hospital remodel.
infect control hosp epidemiol 1997;18(2):104-8.

environmental aerobiological studies in allergic bronchopumonary aspergillosis.
environmental aerobiological studies in allergic bronchopulmonary aspergillosis.

an outbreak of cutaneous aspergillosis in a tertiary-care hospital.
bryce ea, walker m, scharf s et al.

control of construction associated nosocomial aspergillosis in an antiquated hematology unit.
control of construction-associated nosocomial aspergillosis in an antiquated hematology unit.

invasive nosocomial pulmonary aspergillosis: risk factors and hospital building works.
perraud m, piens ma, nicoloyannis n et al.

invasive aspergillosis in immunosuppressed patients: potential hazard of hospital building work.
dewhurst ag, cooper mj, khan sm et al.

chemoprophylaxis for candidosis and aspergillosis in neutropenia and transplantation: a review and recommendations.
working party of the british society for antimicrobial chemotherapy.

efficacy of infection control measures during a nosocomial outbreak of disseminated aspergillosis associated with hospital construction.
opal sm, asp aa, cannady pb et al.

an outbreak of invasive aspergillosis among allogeneic bone marrow transplants: a case-control study.
rotstein c, cummings km, tidings j et al.

airborne fungal spore monitoring in a protective environment during hospital construction, and correlation with an outbreak of invasive aspergillosis.
iwen pc, davis jc, reed ec et al.

fatal primary cutaneous aspergillosis in a bone marrow transplant recipient: nosocomial acquisition in a laminar-air flow room.
bretagne s, bart-delabesse e, wechsler j et al.

tableau 42 : activité anti-leishmanienne sur la forme amastigote molécules cι 50 (μg/ml) promastigotes amastigotes intracellulaires antimoniate de 4300±50 48,7±8,4 méglumine kétoconazole 3±0,5 1,3±0,2 amb 0,029±0,03 0,47+0,05 45 0,1±0,01 1 ,5±0,01 47 0,16+0,04 3,1±0,04 références • abruzzo g.k., flattery et al. gill c.j., kong l., smith j.g., pikounis v.b., balkovec j.m., bouffard a.f., dropinski j.f., rosen h., kropp h., bartizai k., evaluation of the echinocandin antifungal mk-0991 (l- 743,872): efficacies in mouse models of disseminated aspergillosis, candidiasis, and cryptococcosis, antimicrob.
gill c. j., kong l., smith j. g., pikounis v. b., balkovec j. m., bouffard a. f., dropinski j. f., rosen h., kropp h., bartizal k., evaluation of the echinocandin antifungal mk-0991 (l-743,872): efficacies in mouse models of disseminated aspergillosis, candidiasis, and cryptococcosis, antimicrob.